202 results on '"Flaumenhaft R"'
Search Results
2. Protein disulfide isomerase regulation by nitric oxide maintains vascular quiescence and controls thrombus formation
3. Stretch Receptors Attenuate the Prothrombotic Transformation of the Endothelium
4. Primary Human Lung Alveolus‐on‐a‐chip Model of Intravascular Thrombosis for Assessment of Therapeutics
5. Probing for thiol isomerase activity in thrombi
6. Protein disulfide isomerase denitrosylase activity in platelet activation: OR417
7. Parmodulins act at PAR1 to stimulate cytoprotective genetic program in endothelial cells: OC 54.4
8. Human clinical trials evaluating protein disulfide isomerase as an antithrombotic arget: pharmacodynamic and pharmacokinetic studies of oral quercetin and isoquercetin: OC 16.3
9. Parmodulins target the intracellular side of PAR1 to selectively interfere with Gaq but not Ga12/13 signaling and block thrombus formation, but not hemostasis: OC 09.2
10. Membrane remodeling during platelet spreading requires Munc13–4-dependent exocytosis of α-granules expressing VAMP7: O-TH-100
11. Mechanism and therapy of fat embolism: O-TH-059
12. Development of antithrombotic allosteric modulators of PAR1: O-TH-024
13. A small molecule inhibitor of protein disulfide isomerase inhibits thrombus formation in a mouse laser-induced thrombosis model: O-TH-020
14. Chemical Biology
15. Fluoxetine (Prozac) augments platelet activation mediated through protease-activated receptors
16. Illustrated State-of-the-Art Capsules of the ISTH 2019 Congress in Melbourne, Australia
17. Thrombus formation: direct real-time observation and digital analysis of thrombus assembly in a living mouse by confocal and widefield intravital microscopy
18. Shiga Toxins Do Not Directly Stimulate Alpha-Granule Secretion or Enhance Aggregation of Human Platelets
19. Primary Human Lung Alveolus‐on‐a‐chip Model of Intravascular Thrombosis for Assessment of Therapeutics
20. Structure of PAItrap, an uPA mutant
21. Discovery-Based Strategies for Studying Platelet Function
22. Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells.
23. The extracellular regulation of growth factor action.
24. Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity.
25. The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women.
26. Clinical relevance of microparticles from platelets and megakaryocytes.
27. Association of oral but not transdermal estrogen therapy with enhanced platelet reactivity in a subset of postmenopausal women.
28. Localization and quantification of platelet-rich thrombi in large blood vessels with near-infrared fluorescence imaging.
29. Growth factor control of extracellular proteolysis
30. Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor.
31. Proteins of the exocytotic core complex mediate platelet alpha-granule secretion. Roles of vesicle-associated membrane protein, SNAP-23, and syntaxin 4.
32. Inhibition of calpain blocks platelet secretion, aggregation, and spreading.
33. Extracellular matrix regulation of growth factor and protease activity
34. Gain-of-function CEBPE mutation causes noncanonical autoinflammatory inflammasomopathy
35. Btk inhibition: the importance of being selective.
36. Assessing the risk of venous thromboembolism and bleeding among patients with myeloproliferative neoplasms undergoing total knee and hip arthroplasty.
37. Targeting cargo to an unconventional secretory system within megakaryocytes allows the release of transgenic proteins from platelets.
38. Mechanistic basis of activation and inhibition of Protein Disulfide Isomerase by allosteric antithrombotic compounds.
39. Platelets burst your bubble.
40. Protocol to identify flavonoid antagonists of the SARS-CoV-2 main protease.
41. Cryo-EM structure and functional basis of prothrombin recognition by a type I antiprothrombin antiphospholipid antibody.
42. Interferons prime the endothelium for toll-like receptor-mediated thrombin generation.
43. Designer high-density lipoprotein particles enhance endothelial barrier function and suppress inflammation.
44. The unfolded protein response links ER stress to cancer-associated thrombosis.
45. Plant flavonoid inhibition of SARS-CoV-2 main protease and viral replication.
46. Sulfenylation links oxidative stress to protein disulfide isomerase oxidase activity and thrombus formation.
47. TMEM16E regulates endothelial cell procoagulant activity and thrombosis.
48. Enhanced inhibition of protein disulfide isomerase and anti-thrombotic activity of a rutin derivative: rutin:Zn complex.
49. Dematin Regulates Calcium Mobilization, Thrombosis, and Early Akt Activation in Platelets.
50. Platelets: out of shape and misbehaving.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.